Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019). [PDF]
Pulm CircChronic thromboembolic pulmonary hypertension (CTEPH) is a sequela of a pulmonary embolus that occurs in approximately 1%−3% of patients. Pulmonary thromboendoarterectomy (PTE) can be a curative procedure, but balloon pulmonary angioplasty (BPA) has ...
Vohra AS +12 more
europepmc +3 more sources
Arterial lactate levels and their prognostic value in patients undergoing pulmonary thromboendarterectomy [PDF]
Archivos Peruanos de Cardiología y Cirugía Cardiovascular, 2021 Objective. Evaluate the change of lactate levels and its prognostic role in the postoperative period of patients undergoing pulmonary thromboendarterectomy. Methods. Retrospective study between 2001 and 2019.
Cristhian Felipe Ramirez Ramos +12 more
doaj +2 more sources
Pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension: the Spanish experience. [PDF]
Ann Cardiothorac Surg, 2022 Background: Chronic thromboembolic pulmonary hypertension (CTEPH) can be cured by pulmonary endarterectomy (PEA). It is considered the best and only curable treatment option for patients with accessible lesions evaluated as optimal candidates.
López-Gude MJ +7 more
europepmc +2 more sources
Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension [PDF]
Thorax, 1999 Considerable progress has been made in the diagnosis and management of acute pulmonary thromboembolism (PTE) but there are few data about the true incidence, early mortality, and long term progress of this condition. Recurrent PTE or incomplete resolution of the initial event leading to the development of secondary pulmonary hypertension is even less ...
John Dunning, Kathy McNeil
openalex +4 more sources
Successful use of intravenous treprostinil as a bridge to pulmonary thromboendarterectomy. [PDF]
BMJ Case Rep, 2021 Cattran A, Elwing J.
europepmc +3 more sources
Quantifying the learning curve for pulmonary thromboendarterectomy [PDF]
Journal of Cardiothoracic Surgery, 2017 Background Pulmonary thromboendarterectomy (PTE) is an effective treatment for chronic thromboembolic pulmonary hypertension (CTEPH), but is a technically challenging operation for cardiothoracic surgeons.
Smita Sihag +7 more
doaj +2 more sources
Improvements in pulmonary thromboendarterectomy
Revista Portuguesa de Cardiologia, 2020 Paulo M. Pêgo-Fernandes +1 more
doaj +3 more sources
Pulmonary CirculationPulmonary hypertension in sickle cell disease (SCD) is a complex phenomenon resulting from multiple overlapping etiologies, including pulmonary vasoconstriction in the setting of chronic hemolytic anemia, diastolic dysfunction, and chronic thromboembolic
Kadija Hersi +6 more
doaj +2 more sources
Histopathological Evaluation of Pulmonary Thromboendarterectomy Specimens of Chronic Thromboembolic Pulmonary Hypertension. [PDF]
J Atheroscler Thromb, 2023 Aims: Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition with a poor prognosis in which the pulmonary arteries are occluded by organized thrombi.
Obikane H +5 more
europepmc +2 more sources
Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension [PDF]
European Journal of Cardio-Thoracic Surgery, 2022 OBJECTIVE Pulmonary thromboendarterectomy (PTE) is a definitive treatment for chronic thromboembolic pulmonary hypertension (CTEPH). Demographic-based disparities in PTE outcomes have not been well studied.
Austin Y Su +8 more
openalex +2 more sources